News

Pharmabiz1d
Zydus Medtech & Braile Biomedica of Brazil enter global licensing pact to commercialise TAVI technology
Zydus Medtech & Braile Biomedica of Brazil enter global licensing pact to commercialise TAVI technology: Our Bureau, Mumbai ...
Pharmabiz1d
Bavarian State Govt to give fillip to Karnataka life science cos by infusing expertise in technology
Nandita Vijayasimha, Bengaluru Saturday, April 19, 2025, 08:00 Hrs [IST] ...
Pharmabiz1d
Physiotherapy bridges gap between medical interventions and holistic recovery: Dr. Sumandeep Kaur
Physiotherapy bridges gap between medical interventions and holistic recovery: Dr. Sumandeep Kaur: Nandita Vijayasimha, Bengaluru Saturday, April 19, 2025, 08:00 Hrs [IST] Physiot ...
Pharmabiz1d
NABL rolls out amended accreditation criteria for QA testing of diagnostic radiology X-Ray equipment
NABL rolls out amended accreditation criteria for QA testing of diagnostic radiology X-Ray equipment: Shardul Nautiyal, Mumbai Saturday, April 19, 2025, 08:00 Hrs [IST] In a move ...
Pharmabiz1d
Panel asks DoP to expedite setting up of PMRUs in remaining States
Panel asks DoP to expedite setting up of PMRUs in remaining States: Gireesh Babu, New Delhi Saturday, April 19, 2025, 08:00 Hrs [IST] The Parliamentary Panel on Chemicals and Fert ...
Pharmabiz1d
Pharmacists’ role is essential to reshape Indian healthcare delivery system: Kamal Mehrotra
Pharmacists’ role is essential to reshape Indian healthcare delivery system: Kamal Mehrotra: Peethaambaran Kunnathoor, Chennai Saturday, April 19, 2025, 08:00 Hrs [IST] For resh ...
Pharmabiz1d
GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices
GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices: London, UK Saturday, April 19, 2025, 13:00 Hrs ...
Pharmabiz1d
Lupin’s injectable facility in Nagpur receives EIR from US FDA
Lupin’s injectable facility in Nagpur receives EIR from US FDA: Our Bureau, Mumbai Saturday, April 19, 2025, 13:40 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced ...
Pharmabiz1d
Cullinan Therapeutics gets EMA approval to begin phase 1 trial of CLN-978, a bispecific CD19 T cell engager administered RA
Cambridge, Massachusetts Saturday, April 19, 2025, 15:00 Hrs [IST] ...
Pharmabiz1d
Autonomix Medical receives European patent for proprietary catheter-based technology
Autonomix Medical receives European patent for proprietary catheter-based technology: The Woodlands, Texas Saturday, April 19, 2025, 14:00 Hrs [IST] Autonomix Medical, Inc., a med ...
Pharmabiz1d
ACIP votes to expand recommendation for Pfizer’s RSV vaccine Abrysvo to include adults aged 50 to 59 at increased risk of disease
the prevention of LRTD caused by RSV in people 18 through 59 years of age who are at increased risk for LRTD caused by RSV pregnant individuals at 32 through 36 weeks gestational age for the ...
Pharmabiz1d
Chime Biologics and Polpharma Biologics partner to advance biosimilar development
Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, announced a strategic cooperation agreement with Polpharma Biologics to advance the end-to-end development and ...